Neptune Wellness Solutions Inc. (“Neptune” or the “Company“) (NASDAQ:NEPT) (TSX:NEPT), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, announced today that it has applied and received approval for a voluntary delisting of its common shares from the Toronto Stock Exchange (“TSX“). The delisting from the TSX will not affect the Company’s listing on the Nasdaq Capital Market (the “Nasdaq“).
Tempest Therapeutics Q4 EPS $(0.63) Beats $(0.76) Estimate
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.76) by 17.11 percent. This is a 3250 percent decrease over earnings of $0.02 per share
